This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Clinical features

Authoring team

Characteristic early cutaneous features are small blisters and erosions on the backs of the hands, the forearms and the face following minor trauma, and primarily on light-exposed skin. The bullae are thin-walled and rupture easily, resulting in ulcerated skin lesions that heal slowly (1). The skin is more fragile especially on the dorsa of the hands but also occasionally on the feet. There may be numerous small milia particularly on the fingers and hands; these present as yellowish white, spherical keratin containing cysts, 1 to 5 mm in diameter.

Additionally, there may be areas of hyper- and hypo- pigmentation which may resemble chloasma. The central part of the face, particularly the periorbital areas, may be purplish red as in polycythaemia rubra vera.

Hypertrichosis may be evident. Women often present because of hair growth on the cheeks and on the forehead between the eyes; men complain of increasing difficulty to shave.

Sclerodermoid plaques may develop on both light exposed and less covered body areas. These tend to be scattered, waxy yellow to white, indurated plaques. Photodamage of conjunctival sclerae may be seen (2).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.